https://clinicaltrials.gov/ct2/show/NCT04360044?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Conditions : Migraine; Cannabis; THC; CBD
Interventions : Drug: THC ~4%; Drug: CBD ~6%; Drug: THC ~4% and CBD ~6%; Drug: Sham Cannabis
Sponsors : University of California, San Diego; Migraine Research Foundation
Not yet recruiting
Cannabis for Acute Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial
NCT04360044
Fri, 24 Apr 2020 12:00:00 EDT
Last Update Posted: 04/24/20 07:26AM
